# Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-cabozantinib-and-nivolumab-convert-locally-advanced-hepatocellular/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Won Jin Ho,Qingfeng Zhu,Jennifer N. Durham,Aleksandra Popović,Stephanie Xavier,James M. Leatherman,Aditya Mohan,Guanglan Mo,Shu Zhang,Nicole Groß,Soren Charmsaz,Dongxia Lin,Derek Quong,Brad Wilt,Ihab R. Kamel,Matthew J. Weiss,Benjamin Philosophe,Richard A. Burkhart,William R. Burns,Chris Shubert,Aslam Ejaz,Jin He,Atul Deshpande,Ludmila Danilova,Genevieve Stein-O’Brien,Elizabeth A. Sugar,Daniel A. Laheru,Robert A. Anders,Elana J. Fertig,Elizabeth M. Jaffee,Mark Yarchoan |
| Citations | 356 |
| DOI | 10.1038/s43018-021-00234-4 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/8594857 |
| OpenAlex ID | https://openalex.org/W3186127018 |
| PMID | 34796337 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Matthew J. Weiss](https://scholariq.org/researchers/matthew-j-weiss/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.